Tela Bio, Inc. revenue decreases to $11.91 million in quarter ended Mar 31, 2023 from previous quarter
Key fundamental financials
loss of $12.03 million
Revenue of $11.91 million
Current Reporting
Revenue
Net Income
Profit/Loss
Mar 2023
$11.91 million
$12.03 million
loss
Sep 2022
$11,159
$10,714
loss
Jun 2022
$10.41 million
$12.74 million
loss
Tela Bio, Inc. [TELA] has reported $12.03 million loss for the fiscal quarter ending Mar 31, 2023.
Revenue for the quarter was $11.91 million with operating income of $11.25 million.
The Malvern, Pennsylvania (PA)-based company operating in the surgical & medical instruments & apparatus sector has total shareholders equity of $3.14 million.